Interview with Krisja Vermeylen, Vice President Novo Nordisk France &…
Novo Nordisk just celebrated 50 years in France; what have been some of the more recent events that have marked the…
Address: Coeur Défense, Tour B 100, Esplanade Charles de Gaulle, 92932 La Défense Cedex
Tel: 01 41 97 66 00
Web: http://www.novonordisk.fr/documents/home_page/document/index.asp
Novo Nordisk is a global healthcare company with 87 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Headquartered in Denmark, Novo Nordisk employs more than 29,300 employees in 76 countries, and markets its products in 179 countries.
Haemophilia care, growth hormone therapy and hormone replacement therapy.
Novo Nordisk just celebrated 50 years in France; what have been some of the more recent events that have marked the…
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…
The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…
A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…
A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s…
Sanofi has agreed a deal to buy out its partner, US biotech company Principia Biopharma for USD 3.7 billion in…
With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe…
French firm LFB is targeting the lucrative US market with its hemophilia products and recently received two FDA…
French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679…
David Loew, formerly executive vice president of Sanofi Pasteur, Sanofi’s vaccines division, was appointed…
Emmanuel Macron and Angela Merkel recently put their heads together to come up with a health strategy that would…
In a recent interview with Financial Times, Sanofi CEO Paul Hudson set out to clarify some recent comments that the…
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…